Skip to main content

News

A new validation that brings excellence to Mikrobiomik and to the pharmaceutical industry
09/09/2024

A new validation that brings excellence to Mikrobiomik and to the pharmaceutical industry

09/09/24 As a disruptive and pioneering company, Mikrobiomik has achieved a significant milestone by introducing…
A success story on compassionate use
23/06/2024

A success story on compassionate use

23/06/2024 “This woman has already benefited from Spanish stool-based pill to kill dangerous bacteria” The…
The story behind the patients in the ICD-01 clinical trial
13/06/2024

The story behind the patients in the ICD-01 clinical trial

13/06/2024 For statistical purposes, a patient is part of the "n" of the clinical trial,…
AseBio 2023 Report: Milestones and challenges for Spanish Biotech
12/06/2024

AseBio 2023 Report: Milestones and challenges for Spanish Biotech

12/06/2024 AseBio – (Spanish Asociation of biotech companies) presented the AseBio 2023 Report "25 years…
Mikrobiomik makes impact at BIO2024
07/06/2024

Mikrobiomik makes impact at BIO2024

07/06/2024 In June, one of the most significant events for biotechnology worldwide companies, the BIO2024…
“The Economist, special Health”
14/05/2024

“The Economist, special Health”

14/05/2024 An innovation, both in form and substance, is making headway in northern Spain. The…
Market Access Mentoring for Pymes from AseBio and Alira Health
09/05/2024

Market Access Mentoring for Pymes from AseBio and Alira Health

09/05/2024 Through a selection process, Mikrobiomik has been selected to participate in the Market Access…
Celebrating Female Talent at Mikrobiomik
08/03/2024

Celebrating Female Talent at Mikrobiomik

On Friday, March 8th, at Mikrobiomik, we took a moment to honor and celebrate the…
Scientific Advisory in Santander
07/03/2024

Scientific Advisory in Santander

  On March 11th, took place the Mikrobiomik Scientific Advisory Board, a meeting that we…
“Stories that Give Life” AseBio campaign
18/01/2024

“Stories that Give Life” AseBio campaign

As part of the campaign promoted by AseBio (Spanish Association of Biotechnology Companies) called "Stories…
Early closure of clinical trial ICD-01
11/12/2023

Early closure of clinical trial ICD-01

On November 15th of this year, with our CRO "Sermes", we informed to the AEMPS…
Mikrobiomik closes €1.1 million capital increase
26/09/2023

Mikrobiomik closes €1.1 million capital increase

On Wednesday, July 5, Mikrobiomik won the award for Best Idea/Project, after having reached the…
Winners of the “Toribio Echevarría” for Best Idea/Project Award
05/07/2023

Winners of the “Toribio Echevarría” for Best Idea/Project Award

On Wednesday, July 5, Mikrobiomik won the award for Best Idea/Project, after having reached the…
Mikrobiomik chosen by Santander Bank among 1,800 SMEs
04/07/2023

Mikrobiomik chosen by Santander Bank among 1,800 SMEs

On Tuesday July 4th, Mikrobiomik was awarded with the “SME Bizkaia” prize in the category…
I MIKROSALUD Workshop
17/06/2023

I MIKROSALUD Workshop

The past Saturday June 17th took place in Bilbao the “I MIKROSALUD WORKSHOP”. The event…
International Biotechnology Day Meeting
16/06/2023

International Biotechnology Day Meeting

On the occasion of the celebration of the International Day of Biotechnology, we met at…
AseBio annual report
14/06/2023

AseBio annual report

AseBio's annual report 'Deep tech to transform the world'. The annual report on Spanish companies…
Mikrobiomik showcase at the Pharma Partnering Summit
26/05/2023

Mikrobiomik showcase at the Pharma Partnering Summit

Mikrobiomik Showcase at the Pharma Partnering Summit in Munich. During the event that took place…
Mikrobiomik focuses on Europe for 2025
22/05/2023

Mikrobiomik focuses on Europe for 2025

Mikrobiomik seeks up to three million in a round and sets its focus on Europe…
Mikrobiomik guest at the Congress of Health Logistics
10/05/2023

Mikrobiomik guest at the Congress of Health Logistics

Mikrobiomik special guest at the Congress of Health Logistics in Galicia. On May 9th, we…
Agreement IRYCIS and Mikrobiomik
28/03/2023

Agreement IRYCIS and Mikrobiomik

IRYCIS and Mikrobiomik sign an agreement for investigations related to the human microbiota.   Last…
Mikrobiomik receives the award “Novel Company”.
28/02/2023

Mikrobiomik receives the award “Novel Company”.

On Monday, February 20th, the company was awarded with the "Novel Company" prize. This award…
Mikrobiomik in the Business section of ABC
02/10/2022

Mikrobiomik in the Business section of ABC

“Companies explore the future of the healthcare industry in gut microbiota” The Basque startup Mikrobiomik,…
Interview on “Nacex” magazine
13/09/2022

Interview on “Nacex” magazine

Interview with Juan Basterra CEO of the company. What is your differential value? The pharmaceutical…
OSASUNBERRI, a project to support the health industry sector in the Basque Country
27/07/2022

OSASUNBERRI, a project to support the health industry sector in the Basque Country

Mikrobiomik receives support from the Osasunberri program The official signing of the Basque Government's support…
Mikrobiomik joins the Board of Directors of the Basque Health Cluster
10/06/2022

Mikrobiomik joins the Board of Directors of the Basque Health Cluster

Mikrobiomik will be part of the new Board of Directors of the Basque Health Cluster…
Seed Capital Bizkaia takes 3% stake in shares of Mikrobiomik
17/03/2022

Seed Capital Bizkaia takes 3% stake in shares of Mikrobiomik

Seed Capital Bizkaia takes 3% stake in shares of Mikrobiomik. Under its remit to promote…
Mikrobiomik on television
12/01/2022

Mikrobiomik on television

Mikrobiomik on TV. Last weekend we had the pleasure of appearing on the ETB programme…
Mikrobiomik receives major grants and subsidies
04/01/2021

Mikrobiomik receives major grants and subsidies

Since its launch, Mikrobiomik has received grants and subsidies amounting to over €600,000. Thanks to…
Mikrobiomik, 2020 CEBEK Emprende Prize
11/12/2020

Mikrobiomik, 2020 CEBEK Emprende Prize

Mikrobiomik is a bio-pharmaceutical company headquartered in Derio, near Bilbao (Spain) that belongs to the…
CEBEK interview with Juan Basterra, CEO of Mikrobiomik
10/12/2020

CEBEK interview with Juan Basterra, CEO of Mikrobiomik

Juan Basterra, CEO of Mikrobiomik, has been interviewed for the CEBEK (Bizkaia Business Confederation) magazine.…
Mikrobiomik reaches final of CEBEK Emprende awards
27/06/2019

Mikrobiomik reaches final of CEBEK Emprende awards

Mikrobiomik was shortlisted as a finalist for the 2nd CEBEK Emprende awards, sponsored by the…
Mikrobiomik moves to BIC Bizkaia
09/05/2019

Mikrobiomik moves to BIC Bizkaia

Mikrobiomik moves to new premises at the BIC Bizkaia business incubator. Just a year after…
Orza invests in Mikrobiomik
16/04/2019

Orza invests in Mikrobiomik

ORZA has shown its confidence in Mikrobiomik with a €400,000 investment as part of the…
Mikrobiomik obtained SME rating from EMA
05/09/2018

Mikrobiomik obtained SME rating from EMA

On 4 July 2018 the European Medicines Agency (EMA) granted an SME rating to Mikrobiomik.…